nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—Leflunomide—systemic lupus erythematosus	0.52	0.644	CbGbCtD
Flutamide—CYP1B1—Dexamethasone—systemic lupus erythematosus	0.0382	0.0474	CbGbCtD
Flutamide—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0243	0.0301	CbGbCtD
Flutamide—CYP3A5—Dapsone—systemic lupus erythematosus	0.0233	0.0288	CbGbCtD
Flutamide—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0202	0.025	CbGbCtD
Flutamide—CYP2C19—Dapsone—systemic lupus erythematosus	0.0188	0.0232	CbGbCtD
Flutamide—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.0168	0.0208	CbGbCtD
Flutamide—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0162	0.0201	CbGbCtD
Flutamide—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0153	0.0189	CbGbCtD
Flutamide—CYP2C19—Prednisone—systemic lupus erythematosus	0.013	0.0161	CbGbCtD
Flutamide—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0123	0.0153	CbGbCtD
Flutamide—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0104	0.0129	CbGbCtD
Flutamide—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0101	0.0125	CbGbCtD
Flutamide—CYP3A4—Dapsone—systemic lupus erythematosus	0.00908	0.0112	CbGbCtD
Flutamide—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00812	0.0101	CbGbCtD
Flutamide—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00787	0.00974	CbGbCtD
Flutamide—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00787	0.00974	CbGbCtD
Flutamide—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00675	0.00836	CbGbCtD
Flutamide—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00666	0.00825	CbGbCtD
Flutamide—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00631	0.00782	CbGbCtD
Flutamide—CYP3A4—Prednisone—systemic lupus erythematosus	0.00629	0.00779	CbGbCtD
Flutamide—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00596	0.00738	CbGbCtD
Flutamide—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00393	0.00486	CbGbCtD
Flutamide—CYP2C19—urine—systemic lupus erythematosus	0.00309	0.0785	CbGeAlD
Flutamide—CYP1A2—urine—systemic lupus erythematosus	0.00253	0.0641	CbGeAlD
Flutamide—CYP3A4—urine—systemic lupus erythematosus	0.00183	0.0464	CbGeAlD
Flutamide—AHR—nephron tubule—systemic lupus erythematosus	0.00182	0.0462	CbGeAlD
Flutamide—CYP2C19—blood plasma—systemic lupus erythematosus	0.00161	0.041	CbGeAlD
Flutamide—AHR—cortex of kidney—systemic lupus erythematosus	0.00156	0.0396	CbGeAlD
Flutamide—CYP1A2—blood plasma—systemic lupus erythematosus	0.00132	0.0335	CbGeAlD
Flutamide—AHR—tendon—systemic lupus erythematosus	0.00129	0.0328	CbGeAlD
Flutamide—CYP3A5—blood plasma—systemic lupus erythematosus	0.00127	0.0323	CbGeAlD
Flutamide—AHR—bone marrow—systemic lupus erythematosus	0.00125	0.0318	CbGeAlD
Flutamide—AHR—lung—systemic lupus erythematosus	0.00113	0.0288	CbGeAlD
Flutamide—CYP1B1—connective tissue—systemic lupus erythematosus	0.00098	0.0249	CbGeAlD
Flutamide—CYP3A4—blood plasma—systemic lupus erythematosus	0.000955	0.0242	CbGeAlD
Flutamide—CYP1B1—nephron tubule—systemic lupus erythematosus	0.000949	0.0241	CbGeAlD
Flutamide—AR—connective tissue—systemic lupus erythematosus	0.000928	0.0235	CbGeAlD
Flutamide—CYP1B1—skin of body—systemic lupus erythematosus	0.000885	0.0224	CbGeAlD
Flutamide—AR—skin of body—systemic lupus erythematosus	0.000838	0.0213	CbGeAlD
Flutamide—CYP1B1—kidney—systemic lupus erythematosus	0.000834	0.0212	CbGeAlD
Flutamide—CYP1B1—cortex of kidney—systemic lupus erythematosus	0.000812	0.0206	CbGeAlD
Flutamide—AR—kidney—systemic lupus erythematosus	0.00079	0.02	CbGeAlD
Flutamide—AR—cortex of kidney—systemic lupus erythematosus	0.000769	0.0195	CbGeAlD
Flutamide—CYP1B1—lymphoid tissue—systemic lupus erythematosus	0.000716	0.0182	CbGeAlD
Flutamide—AR—lymphoid tissue—systemic lupus erythematosus	0.000678	0.0172	CbGeAlD
Flutamide—CYP1B1—tendon—systemic lupus erythematosus	0.000673	0.0171	CbGeAlD
Flutamide—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000656	0.0166	CbGeAlD
Flutamide—AR—tendon—systemic lupus erythematosus	0.000638	0.0162	CbGeAlD
Flutamide—CYP1A1—skin of body—systemic lupus erythematosus	0.000625	0.0159	CbGeAlD
Flutamide—CYP1B1—lung—systemic lupus erythematosus	0.000591	0.015	CbGeAlD
Flutamide—CYP1A1—kidney—systemic lupus erythematosus	0.00059	0.015	CbGeAlD
Flutamide—CYP3A5—kidney—systemic lupus erythematosus	0.000577	0.0146	CbGeAlD
Flutamide—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000562	0.0142	CbGeAlD
Flutamide—AR—lung—systemic lupus erythematosus	0.00056	0.0142	CbGeAlD
Flutamide—CYP1B1—nervous system—systemic lupus erythematosus	0.000547	0.0139	CbGeAlD
Flutamide—CYP1B1—central nervous system—systemic lupus erythematosus	0.000527	0.0134	CbGeAlD
Flutamide—AR—nervous system—systemic lupus erythematosus	0.000518	0.0131	CbGeAlD
Flutamide—AR—central nervous system—systemic lupus erythematosus	0.000499	0.0127	CbGeAlD
Flutamide—CYP3A4—kidney—systemic lupus erythematosus	0.000433	0.011	CbGeAlD
Flutamide—CYP1A2—lung—systemic lupus erythematosus	0.000424	0.0107	CbGeAlD
Flutamide—CYP1A1—lung—systemic lupus erythematosus	0.000418	0.0106	CbGeAlD
Flutamide—CYP3A5—lung—systemic lupus erythematosus	0.000409	0.0104	CbGeAlD
Flutamide—CYP1A1—nervous system—systemic lupus erythematosus	0.000387	0.00982	CbGeAlD
Flutamide—CYP1A1—central nervous system—systemic lupus erythematosus	0.000373	0.00945	CbGeAlD
Flutamide—AHR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000361	0.0129	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000355	0.0127	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—RXRA—systemic lupus erythematosus	0.000336	0.012	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	0.000335	0.0119	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	0.000329	0.0117	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.000319	0.0114	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	0.000319	0.0114	CbGpPWpGaD
Flutamide—AR—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000305	0.0108	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	0.000302	0.0108	CbGpPWpGaD
Flutamide—CYP3A4—nervous system—systemic lupus erythematosus	0.000284	0.0072	CbGeAlD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.000277	0.00987	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	0.000277	0.00986	CbGpPWpGaD
Flutamide—AR—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000276	0.00982	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—NR3C1—systemic lupus erythematosus	0.000274	0.00976	CbGpPWpGaD
Flutamide—CYP3A4—central nervous system—systemic lupus erythematosus	0.000273	0.00693	CbGeAlD
Flutamide—AHR—Adipogenesis—FAS—systemic lupus erythematosus	0.000266	0.00946	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000261	0.00929	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	0.000259	0.00922	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	0.000259	0.00922	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	0.000251	0.00893	CbGpPWpGaD
Flutamide—AR—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000248	0.00884	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000247	0.0088	CbGpPWpGaD
Flutamide—AR—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000241	0.00857	CbGpPWpGaD
Flutamide—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.00024	0.00192	CcSEcCtD
Flutamide—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.00024	0.00192	CcSEcCtD
Flutamide—Fatigue—Leflunomide—systemic lupus erythematosus	0.000238	0.0019	CcSEcCtD
Flutamide—Erythema—Prednisolone—systemic lupus erythematosus	0.000237	0.0019	CcSEcCtD
Flutamide—Ill-defined disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000236	0.00189	CcSEcCtD
Flutamide—Constipation—Leflunomide—systemic lupus erythematosus	0.000236	0.00189	CcSEcCtD
Flutamide—Malaise—Cyclosporine—systemic lupus erythematosus	0.000235	0.00188	CcSEcCtD
Flutamide—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000235	0.00188	CcSEcCtD
Flutamide—AR—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000233	0.00831	CbGpPWpGaD
Flutamide—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000233	0.00187	CcSEcCtD
Flutamide—Erythema—Hydrocortisone—systemic lupus erythematosus	0.000232	0.00185	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000232	0.00824	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000232	0.00824	CbGpPWpGaD
Flutamide—Malaise—Mycophenolate mofetil—systemic lupus erythematosus	0.000229	0.00183	CcSEcCtD
Flutamide—Erectile dysfunction—Prednisone—systemic lupus erythematosus	0.000228	0.00182	CcSEcCtD
Flutamide—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000228	0.00182	CcSEcCtD
Flutamide—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000227	0.00182	CcSEcCtD
Flutamide—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000225	0.0018	CcSEcCtD
Flutamide—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000223	0.00179	CcSEcCtD
Flutamide—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000223	0.00792	CbGpPWpGaD
Flutamide—Anxiety—Cyclosporine—systemic lupus erythematosus	0.000221	0.00177	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.00022	0.00176	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisolone—systemic lupus erythematosus	0.00022	0.00176	CcSEcCtD
Flutamide—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000219	0.00176	CcSEcCtD
Flutamide—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000219	0.00175	CcSEcCtD
Flutamide—Erythema—Triamcinolone—systemic lupus erythematosus	0.000218	0.00175	CcSEcCtD
Flutamide—AR—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000218	0.00776	CbGpPWpGaD
Flutamide—Erythema—Methylprednisolone—systemic lupus erythematosus	0.000218	0.00174	CcSEcCtD
Flutamide—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.000216	0.00173	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	0.000215	0.00172	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000215	0.00172	CcSEcCtD
Flutamide—Ill-defined disorder—Hydrocortisone—systemic lupus erythematosus	0.000215	0.00172	CcSEcCtD
Flutamide—Confusional state—Cyclosporine—systemic lupus erythematosus	0.000214	0.00172	CcSEcCtD
Flutamide—CYP1A1—Oxidative Stress—JUNB—systemic lupus erythematosus	0.000214	0.00763	CbGpPWpGaD
Flutamide—Malaise—Prednisolone—systemic lupus erythematosus	0.000214	0.00171	CcSEcCtD
Flutamide—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00171	CcSEcCtD
Flutamide—Oedema—Cyclosporine—systemic lupus erythematosus	0.000213	0.0017	CcSEcCtD
Flutamide—AHR—Adipogenesis—PPARG—systemic lupus erythematosus	0.000212	0.00756	CbGpPWpGaD
Flutamide—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.000209	0.00167	CcSEcCtD
Flutamide—Malaise—Hydrocortisone—systemic lupus erythematosus	0.000209	0.00167	CcSEcCtD
Flutamide—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000208	0.00167	CcSEcCtD
Flutamide—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000207	0.00166	CcSEcCtD
Flutamide—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000207	0.00165	CcSEcCtD
Flutamide—Hypertension—Prednisolone—systemic lupus erythematosus	0.000205	0.00164	CcSEcCtD
Flutamide—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000203	0.00163	CcSEcCtD
Flutamide—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000203	0.00162	CcSEcCtD
Flutamide—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000202	0.00162	CcSEcCtD
Flutamide—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000202	0.00162	CcSEcCtD
Flutamide—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000202	0.00161	CcSEcCtD
Flutamide—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.0002	0.0016	CcSEcCtD
Flutamide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.0002	0.0016	CcSEcCtD
Flutamide—Discomfort—Prednisolone—systemic lupus erythematosus	0.000199	0.0016	CcSEcCtD
Flutamide—Erythema—Betamethasone—systemic lupus erythematosus	0.000198	0.00158	CcSEcCtD
Flutamide—Erythema—Dexamethasone—systemic lupus erythematosus	0.000198	0.00158	CcSEcCtD
Flutamide—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000198	0.00158	CcSEcCtD
Flutamide—Asthenia—Leflunomide—systemic lupus erythematosus	0.000198	0.00158	CcSEcCtD
Flutamide—Malaise—Triamcinolone—systemic lupus erythematosus	0.000197	0.00157	CcSEcCtD
Flutamide—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.000196	0.00157	CcSEcCtD
Flutamide—Malaise—Methylprednisolone—systemic lupus erythematosus	0.000196	0.00157	CcSEcCtD
Flutamide—AR—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000196	0.00698	CbGpPWpGaD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000196	0.00157	CcSEcCtD
Flutamide—Pruritus—Leflunomide—systemic lupus erythematosus	0.000195	0.00156	CcSEcCtD
Flutamide—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000195	0.00156	CcSEcCtD
Flutamide—Oedema—Prednisolone—systemic lupus erythematosus	0.000194	0.00155	CcSEcCtD
Flutamide—Dizziness—Azathioprine—systemic lupus erythematosus	0.000193	0.00154	CcSEcCtD
Flutamide—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000192	0.00154	CcSEcCtD
Flutamide—AR—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000192	0.00684	CbGpPWpGaD
Flutamide—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.00019	0.00152	CcSEcCtD
Flutamide—AR—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	0.00019	0.00677	CbGpPWpGaD
Flutamide—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000189	0.00151	CcSEcCtD
Flutamide—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000189	0.00151	CcSEcCtD
Flutamide—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000189	0.00672	CbGpPWpGaD
Flutamide—Photosensitivity reaction—Methotrexate—systemic lupus erythematosus	0.000189	0.00151	CcSEcCtD
Flutamide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000189	0.00151	CcSEcCtD
Flutamide—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000188	0.00151	CcSEcCtD
Flutamide—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000188	0.0015	CcSEcCtD
Flutamide—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.0015	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—FAS—systemic lupus erythematosus	0.000187	0.00667	CbGpPWpGaD
Flutamide—Vomiting—Azathioprine—systemic lupus erythematosus	0.000186	0.00148	CcSEcCtD
Flutamide—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000185	0.00148	CcSEcCtD
Flutamide—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.000185	0.00148	CcSEcCtD
Flutamide—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000184	0.00148	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Rash—Azathioprine—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000184	0.00147	CcSEcCtD
Flutamide—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000183	0.00147	CcSEcCtD
Flutamide—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000183	0.00147	CcSEcCtD
Flutamide—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000183	0.00146	CcSEcCtD
Flutamide—Headache—Azathioprine—systemic lupus erythematosus	0.000183	0.00146	CcSEcCtD
Flutamide—Dizziness—Leflunomide—systemic lupus erythematosus	0.000182	0.00146	CcSEcCtD
Flutamide—Constipation—Cyclosporine—systemic lupus erythematosus	0.000182	0.00146	CcSEcCtD
Flutamide—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.00018	0.00144	CcSEcCtD
Flutamide—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.00018	0.00144	CcSEcCtD
Flutamide—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000179	0.00143	CcSEcCtD
Flutamide—Malaise—Betamethasone—systemic lupus erythematosus	0.000178	0.00143	CcSEcCtD
Flutamide—Malaise—Dexamethasone—systemic lupus erythematosus	0.000178	0.00143	CcSEcCtD
Flutamide—Oedema—Triamcinolone—systemic lupus erythematosus	0.000178	0.00142	CcSEcCtD
Flutamide—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000177	0.00142	CcSEcCtD
Flutamide—Haematuria—Methotrexate—systemic lupus erythematosus	0.000176	0.00141	CcSEcCtD
Flutamide—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000175	0.0014	CcSEcCtD
Flutamide—Vomiting—Leflunomide—systemic lupus erythematosus	0.000175	0.0014	CcSEcCtD
Flutamide—CYP1B1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000175	0.00623	CbGpPWpGaD
Flutamide—Insomnia—Prednisolone—systemic lupus erythematosus	0.000175	0.0014	CcSEcCtD
Flutamide—Rash—Leflunomide—systemic lupus erythematosus	0.000174	0.00139	CcSEcCtD
Flutamide—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000174	0.00139	CcSEcCtD
Flutamide—Nausea—Azathioprine—systemic lupus erythematosus	0.000173	0.00139	CcSEcCtD
Flutamide—Headache—Leflunomide—systemic lupus erythematosus	0.000173	0.00138	CcSEcCtD
Flutamide—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000172	0.00138	CcSEcCtD
Flutamide—Erythema—Prednisone—systemic lupus erythematosus	0.000172	0.00138	CcSEcCtD
Flutamide—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000171	0.00137	CcSEcCtD
Flutamide—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000171	0.00137	CcSEcCtD
Flutamide—Hypertension—Betamethasone—systemic lupus erythematosus	0.000171	0.00137	CcSEcCtD
Flutamide—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000171	0.00137	CcSEcCtD
Flutamide—Anxiety—Betamethasone—systemic lupus erythematosus	0.000168	0.00134	CcSEcCtD
Flutamide—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000168	0.00134	CcSEcCtD
Flutamide—Discomfort—Betamethasone—systemic lupus erythematosus	0.000166	0.00133	CcSEcCtD
Flutamide—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000166	0.00133	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000165	0.00132	CcSEcCtD
Flutamide—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000164	0.00131	CcSEcCtD
Flutamide—Nausea—Leflunomide—systemic lupus erythematosus	0.000164	0.00131	CcSEcCtD
Flutamide—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000163	0.0013	CcSEcCtD
Flutamide—Oedema—Betamethasone—systemic lupus erythematosus	0.000161	0.00129	CcSEcCtD
Flutamide—Oedema—Dexamethasone—systemic lupus erythematosus	0.000161	0.00129	CcSEcCtD
Flutamide—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000161	0.00129	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000161	0.00572	CbGpPWpGaD
Flutamide—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000161	0.00129	CcSEcCtD
Flutamide—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.00016	0.00128	CcSEcCtD
Flutamide—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000159	0.00128	CcSEcCtD
Flutamide—Anaemia—Prednisone—systemic lupus erythematosus	0.000159	0.00127	CcSEcCtD
Flutamide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000158	0.00127	CcSEcCtD
Flutamide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000158	0.00127	CcSEcCtD
Flutamide—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000156	0.00125	CcSEcCtD
Flutamide—Malaise—Prednisone—systemic lupus erythematosus	0.000155	0.00124	CcSEcCtD
Flutamide—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000154	0.00123	CcSEcCtD
Flutamide—Anorexia—Betamethasone—systemic lupus erythematosus	0.000154	0.00123	CcSEcCtD
Flutamide—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000153	0.00123	CcSEcCtD
Flutamide—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000153	0.00123	CcSEcCtD
Flutamide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000153	0.00122	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000152	0.00542	CbGpPWpGaD
Flutamide—AR—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000152	0.00541	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	0.000151	0.00536	CbGpPWpGaD
Flutamide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00015	0.0012	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—PPARG—systemic lupus erythematosus	0.00015	0.00533	CbGpPWpGaD
Flutamide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.00119	CcSEcCtD
Flutamide—Hypertension—Prednisone—systemic lupus erythematosus	0.000149	0.00119	CcSEcCtD
Flutamide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000147	0.00117	CcSEcCtD
Flutamide—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000147	0.00117	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	0.000146	0.00521	CbGpPWpGaD
Flutamide—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000146	0.00117	CcSEcCtD
Flutamide—Anxiety—Prednisone—systemic lupus erythematosus	0.000146	0.00117	CcSEcCtD
Flutamide—Insomnia—Betamethasone—systemic lupus erythematosus	0.000146	0.00117	CcSEcCtD
Flutamide—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000146	0.00117	CcSEcCtD
Flutamide—AHR—Adipogenesis—CDKN1A—systemic lupus erythematosus	0.000146	0.0052	CbGpPWpGaD
Flutamide—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000146	0.00519	CbGpPWpGaD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000146	0.00117	CcSEcCtD
Flutamide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000146	0.00116	CcSEcCtD
Flutamide—Discomfort—Prednisone—systemic lupus erythematosus	0.000145	0.00116	CcSEcCtD
Flutamide—Erythema—Methotrexate—systemic lupus erythematosus	0.000144	0.00115	CcSEcCtD
Flutamide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.00114	CcSEcCtD
Flutamide—CYP1B1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000142	0.00505	CbGpPWpGaD
Flutamide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000141	0.00113	CcSEcCtD
Flutamide—Oedema—Prednisone—systemic lupus erythematosus	0.000141	0.00113	CcSEcCtD
Flutamide—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.00014	0.00112	CcSEcCtD
Flutamide—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.00014	0.00112	CcSEcCtD
Flutamide—Fatigue—Betamethasone—systemic lupus erythematosus	0.000139	0.00111	CcSEcCtD
Flutamide—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000139	0.00111	CcSEcCtD
Flutamide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000137	0.0011	CcSEcCtD
Flutamide—Skin disorder—Prednisone—systemic lupus erythematosus	0.000137	0.00109	CcSEcCtD
Flutamide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000136	0.00109	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	0.000136	0.00482	CbGpPWpGaD
Flutamide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000135	0.00108	CcSEcCtD
Flutamide—CYP1B1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000135	0.00479	CbGpPWpGaD
Flutamide—Rash—Cyclosporine—systemic lupus erythematosus	0.000134	0.00107	CcSEcCtD
Flutamide—Anorexia—Prednisone—systemic lupus erythematosus	0.000134	0.00107	CcSEcCtD
Flutamide—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000134	0.00107	CcSEcCtD
Flutamide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000134	0.00107	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000134	0.00107	CcSEcCtD
Flutamide—Headache—Cyclosporine—systemic lupus erythematosus	0.000133	0.00107	CcSEcCtD
Flutamide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000133	0.00474	CbGpPWpGaD
Flutamide—Anaemia—Methotrexate—systemic lupus erythematosus	0.000133	0.00107	CcSEcCtD
Flutamide—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000133	0.00106	CcSEcCtD
Flutamide—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000133	0.00106	CcSEcCtD
Flutamide—CYP1B1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000133	0.00472	CbGpPWpGaD
Flutamide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00106	CcSEcCtD
Flutamide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000132	0.00469	CbGpPWpGaD
Flutamide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.00105	CcSEcCtD
Flutamide—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.00105	CcSEcCtD
Flutamide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.00104	CcSEcCtD
Flutamide—Malaise—Methotrexate—systemic lupus erythematosus	0.00013	0.00104	CcSEcCtD
Flutamide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000129	0.00103	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000129	0.00103	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—CD4—systemic lupus erythematosus	0.000129	0.00458	CbGpPWpGaD
Flutamide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000128	0.00102	CcSEcCtD
Flutamide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000128	0.00102	CcSEcCtD
Flutamide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00102	CcSEcCtD
Flutamide—AR—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	0.000127	0.00454	CbGpPWpGaD
Flutamide—Insomnia—Prednisone—systemic lupus erythematosus	0.000127	0.00102	CcSEcCtD
Flutamide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000126	0.00101	CcSEcCtD
Flutamide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000126	0.00101	CcSEcCtD
Flutamide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000126	0.00101	CcSEcCtD
Flutamide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000125	0.001	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	0.000123	0.00439	CbGpPWpGaD
Flutamide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000986	CcSEcCtD
Flutamide—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000122	0.000978	CcSEcCtD
Flutamide—AR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000122	0.00435	CbGpPWpGaD
Flutamide—Rash—Prednisolone—systemic lupus erythematosus	0.000122	0.000976	CcSEcCtD
Flutamide—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000122	0.000976	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000122	0.000974	CcSEcCtD
Flutamide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000122	0.000972	CcSEcCtD
Flutamide—Fatigue—Prednisone—systemic lupus erythematosus	0.000121	0.00097	CcSEcCtD
Flutamide—Headache—Prednisolone—systemic lupus erythematosus	0.000121	0.00097	CcSEcCtD
Flutamide—Discomfort—Methotrexate—systemic lupus erythematosus	0.000121	0.000969	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.000121	0.00431	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—CDKN1B—systemic lupus erythematosus	0.000121	0.0043	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—TGFB1—systemic lupus erythematosus	0.000121	0.0043	CbGpPWpGaD
Flutamide—Constipation—Prednisone—systemic lupus erythematosus	0.00012	0.000962	CcSEcCtD
Flutamide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000962	CcSEcCtD
Flutamide—Rash—Hydrocortisone—systemic lupus erythematosus	0.000119	0.000954	CcSEcCtD
Flutamide—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000119	0.000953	CcSEcCtD
Flutamide—Confusional state—Methotrexate—systemic lupus erythematosus	0.000119	0.000948	CcSEcCtD
Flutamide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000948	CcSEcCtD
Flutamide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000118	0.000942	CcSEcCtD
Flutamide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000117	0.00094	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000117	0.00416	CbGpPWpGaD
Flutamide—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000116	0.000927	CcSEcCtD
Flutamide—Asthenia—Betamethasone—systemic lupus erythematosus	0.000116	0.000927	CcSEcCtD
Flutamide—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000116	0.000927	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000115	0.000921	CcSEcCtD
Flutamide—Nausea—Prednisolone—systemic lupus erythematosus	0.000115	0.00092	CcSEcCtD
Flutamide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000114	0.000914	CcSEcCtD
Flutamide—Pruritus—Betamethasone—systemic lupus erythematosus	0.000114	0.000914	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000114	0.000914	CcSEcCtD
Flutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000114	0.00406	CbGpPWpGaD
Flutamide—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000113	0.000906	CcSEcCtD
Flutamide—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000113	0.000903	CcSEcCtD
Flutamide—AHR—Adipogenesis—TNF—systemic lupus erythematosus	0.000113	0.00401	CbGpPWpGaD
Flutamide—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000898	CcSEcCtD
Flutamide—Rash—Triamcinolone—systemic lupus erythematosus	0.000112	0.000898	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.000112	0.00399	CbGpPWpGaD
Flutamide—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000112	0.000897	CcSEcCtD
Flutamide—Anorexia—Methotrexate—systemic lupus erythematosus	0.000112	0.000897	CcSEcCtD
Flutamide—Rash—Methylprednisolone—systemic lupus erythematosus	0.000112	0.000896	CcSEcCtD
Flutamide—AR—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	0.000112	0.00398	CbGpPWpGaD
Flutamide—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000112	0.000895	CcSEcCtD
Flutamide—Headache—Triamcinolone—systemic lupus erythematosus	0.000111	0.000892	CcSEcCtD
Flutamide—Headache—Methylprednisolone—systemic lupus erythematosus	0.000111	0.00089	CcSEcCtD
Flutamide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.00011	0.000884	CcSEcCtD
Flutamide—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.00011	0.000884	CcSEcCtD
Flutamide—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000108	0.00384	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	0.000108	0.00383	CbGpPWpGaD
Flutamide—Dizziness—Betamethasone—systemic lupus erythematosus	0.000107	0.000855	CcSEcCtD
Flutamide—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000107	0.000855	CcSEcCtD
Flutamide—Insomnia—Methotrexate—systemic lupus erythematosus	0.000106	0.000851	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—EP300—systemic lupus erythematosus	0.000106	0.00378	CbGpPWpGaD
Flutamide—Nausea—Triamcinolone—systemic lupus erythematosus	0.000106	0.000846	CcSEcCtD
Flutamide—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000844	CcSEcCtD
Flutamide—Somnolence—Methotrexate—systemic lupus erythematosus	0.000104	0.000836	CcSEcCtD
Flutamide—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000103	0.000822	CcSEcCtD
Flutamide—Vomiting—Betamethasone—systemic lupus erythematosus	0.000103	0.000822	CcSEcCtD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000102	0.00365	CbGpPWpGaD
Flutamide—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000102	0.000818	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000102	0.00363	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	0.000102	0.00363	CbGpPWpGaD
Flutamide—Rash—Betamethasone—systemic lupus erythematosus	0.000102	0.000815	CcSEcCtD
Flutamide—Rash—Dexamethasone—systemic lupus erythematosus	0.000102	0.000815	CcSEcCtD
Flutamide—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000102	0.000814	CcSEcCtD
Flutamide—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000102	0.000814	CcSEcCtD
Flutamide—Fatigue—Methotrexate—systemic lupus erythematosus	0.000101	0.000811	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000101	0.0036	CbGpPWpGaD
Flutamide—Headache—Dexamethasone—systemic lupus erythematosus	0.000101	0.00081	CcSEcCtD
Flutamide—Headache—Betamethasone—systemic lupus erythematosus	0.000101	0.00081	CcSEcCtD
Flutamide—Asthenia—Prednisone—systemic lupus erythematosus	0.000101	0.000807	CcSEcCtD
Flutamide—CYP1B1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000101	0.00358	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	9.97e-05	0.00355	CbGpPWpGaD
Flutamide—Pruritus—Prednisone—systemic lupus erythematosus	9.95e-05	0.000796	CcSEcCtD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	9.81e-05	0.00349	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—EP300—systemic lupus erythematosus	9.8e-05	0.00349	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	9.7e-05	0.00345	CbGpPWpGaD
Flutamide—Feeling abnormal—Methotrexate—systemic lupus erythematosus	9.69e-05	0.000775	CcSEcCtD
Flutamide—AR—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	9.64e-05	0.00343	CbGpPWpGaD
Flutamide—Diarrhoea—Prednisone—systemic lupus erythematosus	9.62e-05	0.00077	CcSEcCtD
Flutamide—Nausea—Dexamethasone—systemic lupus erythematosus	9.59e-05	0.000768	CcSEcCtD
Flutamide—Nausea—Betamethasone—systemic lupus erythematosus	9.59e-05	0.000768	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	9.55e-05	0.0034	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	9.4e-05	0.00335	CbGpPWpGaD
Flutamide—Dizziness—Prednisone—systemic lupus erythematosus	9.3e-05	0.000744	CcSEcCtD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.25e-05	0.00329	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—IL6—systemic lupus erythematosus	9.1e-05	0.00324	CbGpPWpGaD
Flutamide—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	9.03e-05	0.00321	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	8.95e-05	0.00318	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	8.95e-05	0.00318	CbGpPWpGaD
Flutamide—Vomiting—Prednisone—systemic lupus erythematosus	8.94e-05	0.000716	CcSEcCtD
Flutamide—Rash—Prednisone—systemic lupus erythematosus	8.87e-05	0.00071	CcSEcCtD
Flutamide—Dermatitis—Prednisone—systemic lupus erythematosus	8.86e-05	0.000709	CcSEcCtD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.82e-05	0.00314	CbGpPWpGaD
Flutamide—Headache—Prednisone—systemic lupus erythematosus	8.81e-05	0.000705	CcSEcCtD
Flutamide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	8.77e-05	0.00312	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—NAT2—systemic lupus erythematosus	8.77e-05	0.00312	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.74e-05	0.00311	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	8.67e-05	0.00309	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.65e-05	0.00308	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	8.49e-05	0.00302	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	8.47e-05	0.00302	CbGpPWpGaD
Flutamide—Asthenia—Methotrexate—systemic lupus erythematosus	8.43e-05	0.000675	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	8.37e-05	0.00298	CbGpPWpGaD
Flutamide—Nausea—Prednisone—systemic lupus erythematosus	8.35e-05	0.000668	CcSEcCtD
Flutamide—Pruritus—Methotrexate—systemic lupus erythematosus	8.32e-05	0.000665	CcSEcCtD
Flutamide—CYP1A1—Biological oxidations—NAT2—systemic lupus erythematosus	8.28e-05	0.00295	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.17e-05	0.00291	CbGpPWpGaD
Flutamide—Diarrhoea—Methotrexate—systemic lupus erythematosus	8.04e-05	0.000644	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	8.02e-05	0.00286	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	7.78e-05	0.00277	CbGpPWpGaD
Flutamide—Dizziness—Methotrexate—systemic lupus erythematosus	7.77e-05	0.000622	CcSEcCtD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	7.57e-05	0.00269	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—RXRA—systemic lupus erythematosus	7.54e-05	0.00268	CbGpPWpGaD
Flutamide—Vomiting—Methotrexate—systemic lupus erythematosus	7.47e-05	0.000598	CcSEcCtD
Flutamide—Rash—Methotrexate—systemic lupus erythematosus	7.41e-05	0.000593	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—systemic lupus erythematosus	7.4e-05	0.000592	CcSEcCtD
Flutamide—Headache—Methotrexate—systemic lupus erythematosus	7.36e-05	0.000589	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	7.31e-05	0.0026	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	7.26e-05	0.00259	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	7.26e-05	0.00259	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	7.22e-05	0.00257	CbGpPWpGaD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	7.15e-05	0.00255	CbGpPWpGaD
Flutamide—Nausea—Methotrexate—systemic lupus erythematosus	6.98e-05	0.000559	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	6.94e-05	0.00247	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	6.91e-05	0.00246	CbGpPWpGaD
Flutamide—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.88e-05	0.00245	CbGpPWpGaD
Flutamide—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	6.87e-05	0.00245	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	6.87e-05	0.00244	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	6.85e-05	0.00244	CbGpPWpGaD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.84e-05	0.00243	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	6.78e-05	0.00241	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	6.69e-05	0.00238	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.69e-05	0.00238	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—RXRA—systemic lupus erythematosus	6.64e-05	0.00236	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	6.62e-05	0.00236	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	6.61e-05	0.00235	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	6.5e-05	0.00231	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—IL6—systemic lupus erythematosus	6.42e-05	0.00229	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	6.37e-05	0.00227	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	6.27e-05	0.00223	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	6.27e-05	0.00223	CbGpPWpGaD
Flutamide—AR—Gene Expression—MTA2—systemic lupus erythematosus	6.22e-05	0.00221	CbGpPWpGaD
Flutamide—CYP1A1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.2e-05	0.00221	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	6.14e-05	0.00219	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.79e-05	0.00206	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	5.57e-05	0.00198	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.51e-05	0.00196	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	5.51e-05	0.00196	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.31e-05	0.00189	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	5.28e-05	0.00188	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.28e-05	0.00188	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	5.22e-05	0.00186	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.21e-05	0.00185	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.07e-05	0.00181	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—RXRA—systemic lupus erythematosus	4.92e-05	0.00175	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.79e-05	0.0017	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	4.74e-05	0.00169	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—RXRA—systemic lupus erythematosus	4.64e-05	0.00165	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	4.48e-05	0.00159	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.47e-05	0.00159	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.47e-05	0.00159	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	4.41e-05	0.00157	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.3e-05	0.00153	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	4.22e-05	0.0015	CbGpPWpGaD
Flutamide—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	4.2e-05	0.00149	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—PPARG—systemic lupus erythematosus	4.19e-05	0.00149	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	4.17e-05	0.00149	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	4.16e-05	0.00148	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.16e-05	0.00148	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	4.1e-05	0.00146	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	4.08e-05	0.00145	CbGpPWpGaD
Flutamide—AR—Gene Expression—SNRPB—systemic lupus erythematosus	4.07e-05	0.00145	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	4.06e-05	0.00145	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.02e-05	0.00143	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	4e-05	0.00142	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	4e-05	0.00142	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.95e-05	0.00141	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	3.95e-05	0.00141	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	3.94e-05	0.0014	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.92e-05	0.00139	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	3.85e-05	0.00137	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	3.8e-05	0.00135	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	3.76e-05	0.00134	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.69e-05	0.00131	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.63e-05	0.00129	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	3.51e-05	0.00125	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3.51e-05	0.00125	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.46e-05	0.00123	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	3.39e-05	0.00121	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	3.33e-05	0.00118	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	3.3e-05	0.00117	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.27e-05	0.00117	CbGpPWpGaD
Flutamide—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.27e-05	0.00116	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	3.05e-05	0.00109	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.01e-05	0.00107	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.96e-05	0.00105	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.9e-05	0.00103	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.85e-05	0.00102	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.85e-05	0.00102	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	2.83e-05	0.00101	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.81e-05	0.000999	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	2.74e-05	0.000976	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	2.68e-05	0.000956	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	2.66e-05	0.000948	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.62e-05	0.000934	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NAT2—systemic lupus erythematosus	2.3e-05	0.000819	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.29e-05	0.000813	CbGpPWpGaD
Flutamide—AR—Gene Expression—JUNB—systemic lupus erythematosus	2.28e-05	0.000813	CbGpPWpGaD
Flutamide—AR—Gene Expression—RXRA—systemic lupus erythematosus	2e-05	0.000712	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.85e-05	0.000658	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.83e-05	0.000651	CbGpPWpGaD
Flutamide—AR—Gene Expression—VDR—systemic lupus erythematosus	1.81e-05	0.000645	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.78e-05	0.000635	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.64e-05	0.000585	CbGpPWpGaD
Flutamide—AR—Gene Expression—NR3C1—systemic lupus erythematosus	1.63e-05	0.000581	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	1.5e-05	0.000534	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.46e-05	0.000519	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.44e-05	0.000512	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	1.42e-05	0.000504	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—RXRA—systemic lupus erythematosus	1.29e-05	0.000459	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—systemic lupus erythematosus	1.26e-05	0.00045	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.2e-05	0.000426	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.16e-05	0.000413	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.14e-05	0.000405	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.13e-05	0.000401	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.01e-05	0.00036	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.21e-06	0.000328	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	9.03e-06	0.000322	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.86e-06	0.000315	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	8.41e-06	0.000299	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.28e-06	0.000295	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—systemic lupus erythematosus	8.14e-06	0.00029	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	7.94e-06	0.000283	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.37e-06	0.000262	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—systemic lupus erythematosus	7.32e-06	0.000261	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.25e-06	0.000258	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.18e-06	0.000256	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NOS3—systemic lupus erythematosus	7e-06	0.000249	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	6.97e-06	0.000248	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	6.5e-06	0.000231	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.46e-06	0.00023	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—systemic lupus erythematosus	6.4e-06	0.000228	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.03e-06	0.000215	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.65e-06	0.000201	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—systemic lupus erythematosus	5.33e-06	0.00019	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	5.31e-06	0.000189	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.06e-06	0.00018	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	5.01e-06	0.000178	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	4.77e-06	0.00017	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.7e-06	0.000167	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	4.56e-06	0.000162	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	4.51e-06	0.00016	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	4.31e-06	0.000154	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	4.18e-06	0.000149	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	4.1e-06	0.000146	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	3.94e-06	0.00014	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.91e-06	0.000139	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	3.69e-06	0.000131	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	3.53e-06	0.000126	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	3.47e-06	0.000124	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	3.28e-06	0.000117	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	3.23e-06	0.000115	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.2e-06	0.000114	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.87e-06	0.000102	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.75e-06	9.79e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	2.68e-06	9.56e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.52e-06	8.95e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.47e-06	8.78e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.22e-06	7.9e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.12e-06	7.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.09e-06	7.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.94e-06	6.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.61e-06	5.75e-05	CbGpPWpGaD
